The store will not work correctly when cookies are disabled.
[7-Methyl-5-(thiophene-2-carbonyl)-1H-benzoimidazol-2-yl]-carbamic acid methyl ester
ID: ALA341192
PubChem CID: 44354743
Max Phase: Preclinical
Molecular Formula: C15H13N3O3S
Molecular Weight: 315.35
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: COC(=O)Nc1nc2c(C)cc(C(=O)c3cccs3)cc2[nH]1
Standard InChI: InChI=1S/C15H13N3O3S/c1-8-6-9(13(19)11-4-3-5-22-11)7-10-12(8)17-14(16-10)18-15(20)21-2/h3-7H,1-2H3,(H2,16,17,18,20)
Standard InChI Key: DCSRLGCQUZVJSQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
7.4417 -6.5167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9542 -5.8542 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.1750 -6.1042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9542 -7.1875 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.1750 -6.9375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2667 -6.5125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.7500 -6.1042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0375 -5.7000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8542 -5.9292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3250 -6.1125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4542 -7.3500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4542 -5.6917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7500 -6.9375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5667 -5.7750 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
3.2375 -6.9292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0167 -6.3875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6375 -5.1292 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.0292 -4.8667 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.4292 -7.1000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6500 -6.1417 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.4542 -8.1750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2292 -5.5625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 1 2 0
5 4 1 0
6 1 1 0
7 12 1 0
8 7 1 0
9 6 1 0
10 8 1 0
11 5 2 0
12 3 2 0
13 11 1 0
14 10 1 0
15 10 2 0
16 14 1 0
17 9 2 0
18 8 2 0
19 15 1 0
20 9 1 0
21 11 1 0
22 20 1 0
5 3 1 0
7 13 2 0
19 16 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 315.35 | Molecular Weight (Monoisotopic): 315.0678 | AlogP: 3.34 | #Rotatable Bonds: 3 |
Polar Surface Area: 84.08 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.84 | CX Basic pKa: 4.22 | CX LogP: 3.69 | CX LogD: 3.67 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.73 | Np Likeness Score: -1.35 |
References
1. Kruse LI, Ladd DL, Harrsch PB, McCabe FL, Mong SM, Faucette L, Johnson R.. (1989) Synthesis, tubulin binding, antineoplastic evaluation, and structure-activity relationship of oncodazole analogues., 32 (2): [PMID:2913301] [10.1021/jm00122a020] |